Details for New Drug Application (NDA): 201585
✉ Email this page to a colleague
NDA 201585 describes BLISOVI FE 1.5/30, which is a drug marketed by Lupin Ltd and is included in one NDA. It is available from one supplier. Additional details are available on the BLISOVI FE 1.5/30 profile page.
The generic ingredient in BLISOVI FE 1.5/30 is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
The generic ingredient in BLISOVI FE 1.5/30 is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for 201585
| Tradename: | BLISOVI FE 1.5/30 |
| Applicant: | Lupin Ltd |
| Ingredient: | ethinyl estradiol; norethindrone acetate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 201585
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BLISOVI FE 1.5/30 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-28 | 201585 | ANDA | Lupin Pharmaceuticals, Inc. | 68180-866 | 68180-866-73 | 3 POUCH in 1 CARTON (68180-866-73) / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL-28 | Strength | 0.03MG;1.5MG | ||||
| Approval Date: | Nov 18, 2015 | TE: | BX | RLD: | No | ||||
Complete Access Available with Subscription
